Dynavax Technologies (DVAX) Q1 2021 Earnings Call Transcript

Dynavax Technologies (DVAX) Q1 2021 Earnings Call Transcript
·28 min read

Joining me on the call today are Ryan Spencer, chief executive officer; Kelly MacDonald, chief financial officer; Robert Janssen, chief medical officer; and Donn Casale, senior vice president, commercial. Before I begin, I advise you that we will be making forward-looking statements today, including statements regarding HEPLISAV-B's commercial profile, its potential to become the standard of care and for universal recommendation.